Life Scientist > Molecular Biology

The national synchrotron: ray of hope or ring of fire?

17 June, 2002 by Tanya Hollis

When the Victorian Government derailed the national synchrotron bidding process by announcing in June 2001 it would go it alone, it caught many people off guard.


Garvan appoints BioLateral to help set up bio-IT division

13 June, 2002 by Tanya Hollis

Sydney bio-IT company BioLateral has won a three-month contract to help the Garvan Institute of Medical Research establish its $1 million Peter Wills Centre for Bioinformatics.


Promics gets VC vote of confidence

12 June, 2002 by Pete Young

Drug discovery company Promics has received a $2.5 million vote of confidence in its anti-inflammatory candidate PMX 53 from venture capital backers.


Icelandic genome map released

11 June, 2002 by Melissa Trudinger

Icelandic company deCODE Genetics has updated the map of the human genome, estimated to give about five-fold greater resolution than the current draft.


Protein gel offers hope to childless

07 June, 2002 by Tanya Hollis

A pre-intercourse gel derived from a protein found in sperm could prove the key to fertility for thousands of childless couples.


Proteome Systems launches ProteomIQ, moves into Japan

03 June, 2002 by Iain Scott

Sydney-based company Proteome Systems' proteomics R&D system, ProteomIQ, has been launched on the market.


Intelligent Island sets priorities

29 May, 2002 by Pete Young

A head-hunting expedition to find 30 to 40 research staff will be among the first priorities for Tasmania's recently-announced $40 million bioinformatics centre of excellence.


ACT feature: ACT biotech's big players

29 May, 2002 by Melissa Trudinger

As one of the big players in the ACT's biotech scene, the John Curtin School of Medical Research (JCSMR) has already spun out at least two companies. Biotron, listed on the ASX, is one, working on two cancer diagnostic tests and a number of therapeutic agents including an antiviral for treatment of HIV.


South Australian Interview: Dancing with the elephants

21 May, 2002 by Daniella Goldberg

Dr Deborah Rathjen, CEO of listed Adelaide company Bionomics, says there are plenty of positive signs that South Australia has a burgeoning biotechnology industry.


Bioinformatics Centre of Excellence funding announced

20 May, 2002 by Tanya Hollis

Up to $20 million is to be spent setting up Tasmania's Bioinformatics Centre of Excellence, it was announced today.


Tasmanian feature: Wired island

17 May, 2002 by Pete Young

Tasmania's Intelligent Island program has a central focus on bioinformatics, with a proposal to build an R&D centre of excellence that will attract world class researchers to Tasmania, generate IP and spin off commercial companies.


Tasmanian feature: All in the family

17 May, 2002 by Melissa Trudinger

Prof Terry Dwyer is the Director of the Menzies Research Institute, which he established in 1988. The institute is an epidemiology focused research organisation looking at the causes of human diseases.


Victorian feature: Biotech's a real synch

16 May, 2002 by Tanya Hollis and Melissa Trudinger

One word is consistently on people's lips when discussing Victoria's biotechnology scene: hub.


Takara Bio to mass produce microarray DNA fragments

15 May, 2002 by Kuriko Miyake

Takara Bio, a biotechnology company in Otsu, Japan, has developed a system which allows for mass production of a wide variety of DNA (deoxyribonucleic acid) fragments needed to make DNA microarrays, the company announced Tuesday May 14.


The university of bioinformatics

13 May, 2002 by Pete Young

It used to be that biology students would run a mile from anything that smacked of computing. Now, with bio-IT touted as an indispensable element of the life sciences, what's changed?


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd